Humana Inc. (HUM) wird mit einem nachlaufenden KGV von gehandelt 19.8, erwartetes KGV von 21.7. Die nachlaufende Gewinnrendite beträgt 5.05%, erwartete Gewinnrendite 4.61%. PEG 0.47 (Peter Lynch unterbewertet ≤1,0). Die Graham-Zahl beträgt $180.94.
Durch diese Seite bewiesene Kriterien:
SharesGrow Gesamtbewertung: 53/100 mit 2/7 Kriterien bestanden.
| Year | P/E (TTM) | PEG-Verhältnis | P/B-Verhältnis | P/S-Verhältnis | Dividendenrendite |
|---|---|---|---|---|---|
| 2016 | 49.6 | -0.96 | 2.85 | 0.56 | 0.58% |
| 2017 | 14.6 | 0.05 | 3.64 | 0.67 | 0.61% |
| 2018 | 23.4 | -0.84 | 3.88 | 0.69 | 0.67% |
| 2019 | 18.2 | 0.28 | 4.08 | 0.76 | 0.59% |
| 2020 | 16.1 | 0.62 | 3.95 | 0.70 | 0.60% |
| 2021 | 20.4 | -1.93 | 3.71 | 0.71 | 0.59% |
| 2022 | 23.1 | -8.91 | 4.23 | 0.70 | 0.61% |
| 2023 | 22.8 | -2.40 | 3.49 | 0.53 | 0.76% |
| 2024 | 25.3 | -0.51 | 1.87 | 0.26 | 1.41% |
| 2025 | 26.0 | -18.57 | 1.75 | 0.24 | 1.39% |
| Year | EPS (verwässert) | Umsatz | Nettogewinn | Nettomarge |
|---|---|---|---|---|
| 2016 | $4.07 | $54.38B | $614M | 1.1% |
| 2017 | $16.81 | $53.77B | $2.45B | 4.6% |
| 2018 | $12.16 | $56.91B | $1.68B | 3% |
| 2019 | $20.10 | $64.89B | $2.71B | 4.2% |
| 2020 | $25.31 | $77.16B | $3.37B | 4.4% |
| 2021 | $22.67 | $83.06B | $2.93B | 3.5% |
| 2022 | $22.08 | $92.87B | $2.81B | 3% |
| 2023 | $20.00 | $106.37B | $2.49B | 2.3% |
| 2024 | $9.98 | $117.76B | $1.21B | 1% |
| 2025 | $9.84 | $129.66B | $1.19B | 0.9% |
| Year | EPS (Durchschn.) | EPS-Spanne | Umsatz (Durchschn.) | Umsatzspanne | Analysten |
|---|---|---|---|---|---|
| 2026 | $9.22 | $7.79 – $12.83 | $160.62B | $140.09B – $168.25B | 16 |
| 2027 | $15.28 | $11.97 – $19.25 | $170.67B | $149.15B – $183.95B | 15 |
| 2028 | $26.71 | $18.98 – $36.14 | $183.11B | $182.44B – $183.77B | 7 |
| 2029 | $38.84 | $32.40 – $42.06 | $192.72B | $168.13B – $205.03B | 2 |
| 2030 | $41.63 | $34.72 – $45.09 | $204.44B | $178.35B – $217.49B | 5 |
